相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: Finding ways for prevention
Plamena R. Angelova et al.
MEDICINAL RESEARCH REVIEWS (2021)
Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis
Simon Couly et al.
HUMAN MOLECULAR GENETICS (2020)
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin
Chen-hong Guo et al.
ACTA PHARMACOLOGICA SINICA (2020)
Therapeutic Advances for Huntington's Disease
Ashok Kumar et al.
BRAIN SCIENCES (2020)
Fenfluramine acts as a positive modulator of sigma-1 receptors
Parthena Martin et al.
EPILEPSY & BEHAVIOR (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Clinical trials of new drugs for Alzheimer disease
Li-Kai Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study
Harald Hampel et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Sigma-1 Receptor Agonists Induce Oxidative Stress in Mitochondria and Enhance Complex I Activity in Physiological Condition but Protect Against Pathological Oxidative Stress
Nino Goguadze et al.
NEUROTOXICITY RESEARCH (2019)
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
Ralf Reilmann et al.
LANCET NEUROLOGY (2019)
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease
Veronica Francardo et al.
NEUROTHERAPEUTICS (2019)
Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model
Ariel Ionescu et al.
CELL DEATH & DISEASE (2019)
Allosteric Modulators of Sigma-1 Receptor
Edijs Vavers et al.
FRONTIERS IN PHARMACOLOGY (2019)
Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo
Maximilian G. Christ et al.
CELLS (2019)
Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor
Daniel Ryskamp et al.
NEUROBIOLOGY OF DISEASE (2019)
Impairment and Restoration of Homeostatic Plasticity in Cultured Cortical Neurons From a Mouse Model of Huntington Disease
Amy Smith-Dijak et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
Anna Tesei et al.
FRONTIERS IN PHARMACOLOGY (2019)
The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson's Disease (PD) and Major Depressive Disorder (MDD)
Kai Yang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Novel missense alleles of SIGMAR1 as tools to understand emerin-dependent gene silencing in response to cocaine
Adith S. Arun et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ1 receptors
Tangui Maurice et al.
PHARMACOLOGICAL RESEARCH (2019)
Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease A Phase 2 Randomized Clinical Trial
Lon S. Schneider et al.
JAMA NEUROLOGY (2019)
Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor
Chelsy R. Eddings et al.
NEUROBIOLOGY OF DISEASE (2019)
Non-canonical Targets Mediating the Action of Drugs of Abuse: Cocaine at the Sigma-1 Receptor as an Example
Tsung-Ping Su
FRONTIERS IN NEUROSCIENCE (2019)
Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease
Mikhail V. Voronin et al.
SCIENTIFIC REPORTS (2019)
The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer
Olivier Soriani et al.
FRONTIERS IN NEUROSCIENCE (2019)
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
Tom H. Johnston et al.
MOVEMENT DISORDERS (2019)
Glial mitochondrial function and dysfunction in health and neurodegeneration
Kevin McAvoy et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP3-Evoked Ca2+ Signals through Sigma-1 Receptors
Eugen Brailoiu et al.
CELL REPORTS (2019)
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
Michael Grundman et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
APEX2-tagging of Sigma 1-receptor indicates subcellular protein topology with cytosolic N-terminus and ER luminal C-terminus
Timur Mavylutov et al.
PROTEIN & CELL (2018)
AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease
Helene Hall et al.
ALZHEIMERS & DEMENTIA (2018)
Riluzole, disease stage and survival in ALS
Thanuja Dharmadasa et al.
LANCET NEUROLOGY (2018)
Sigma Receptors as Endoplasmic Reticulum Stress Gatekeepers and their Modulators as Emerging New Weapons in the Fight Against Cancer
Anna Tesei et al.
FRONTIERS IN PHARMACOLOGY (2018)
Structural basis for σ1 receptor ligand recognition
Hayden R. Schmidt et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Sigma-1 receptor and amyotrophic lateral sclerosis
Eduardo E. Benarroch
NEUROLOGY (2018)
Compound heterozygote mutations in the SIGMAR1 gene in an oldest-old patient with amyotrophic lateral sclerosis
Yuishin Izumi et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2018)
Mitochondria-Associated Membranes (MAMs): Overview and Its Role in Parkinson's Disease
M. Rodriguez-Arribas et al.
MOLECULAR NEUROBIOLOGY (2017)
Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease
Bitna Yi et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Rab32 connects ER stress to mitochondrial defects in multiple sclerosis
Yohannes Haile et al.
JOURNAL OF NEUROINFLAMMATION (2017)
A call for new approaches to Alzheimer's disease research
Paul D. Coleman et al.
NEUROBIOLOGY OF AGING (2017)
Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies
Bilal Khalil et al.
NEUROBIOLOGY OF AGING (2017)
Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia
Dhwanil A. Dalwadi et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Identification of the gene that codes for the σ2 receptor
Assaf Alon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma
Lucia Longhitano et al.
ONCOTARGET (2017)
Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice
Marta Garcia-Miralles et al.
JCI INSIGHT (2017)
AF710B, a Novell M1/sigma 1 Agonist With Therapeutic Efficacy on Animal Models of Alzheimer's Disease
Abraham Fisher et al.
NEURODEGENERATIVE DISEASES (2016)
The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline
Roderick A. Corriveau et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS
Seiji Watanabe et al.
EMBO MOLECULAR MEDICINE (2016)
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
Michal Geva et al.
HUMAN MOLECULAR GENETICS (2016)
Activation of σ1 and σ2 receptors by afobazole increases glial cell survival and prevents glial cell activation and nitrosative stress after ischemic stroke
Christopher Katnik et al.
JOURNAL OF NEUROCHEMISTRY (2016)
The clinical symptoms of Parkinson's disease
Sigurlaug Sveinbjornsdottir
JOURNAL OF NEUROCHEMISTRY (2016)
SIGMA-1 RECEPTOR EXPRESSION IN THE DORSAL ROOT GANGLION: REEXAMINATION USING A HIGHLY SPECIFIC ANTIBODY
Timur A. Mavlyutov et al.
NEUROSCIENCE (2016)
There's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative Diseases
Sebastien Paillusson et al.
TRENDS IN NEUROSCIENCES (2016)
The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems
Tsung-Ping Su et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Biochemical Pharmacology of the Sigma-1 Receptor
Uyen B. Chu et al.
MOLECULAR PHARMACOLOGY (2016)
The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands
Ashish K. Mishra et al.
BIOCHEMICAL JOURNAL (2015)
Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
Ferdinando Squitieri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease
Yasuo Miki et al.
NEUROBIOLOGY OF DISEASE (2015)
Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope
Shang-Yi A. Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses
Kristoffer Sahlholm et al.
PSYCHOPHARMACOLOGY (2015)
Subcellular Localization of the Sigma-1 Receptor in Retinal Neurons - an Electron Microscopy Study
Timur A. Mavlyutov et al.
SCIENTIFIC REPORTS (2015)
Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism
Veronica Francardo et al.
BRAIN (2014)
The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors
L. Zvejniece et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
alpha-Synuclein Is Localized to Mitochondria-Associated ER Membranes
Cristina Guardia-Laguarta et al.
JOURNAL OF NEUROSCIENCE (2014)
Treatment with afobazole at delayed time points following ischemic stroke improves long-term functional and histological outcomes
C. Katnik et al.
NEUROBIOLOGY OF DISEASE (2014)
Neuroprotective effects of the Sigma-1 receptor (SIR) agonist PRE-084, in a mouse model of moter neuron disease not linked to SOD1 mutation
Marco Peviani et al.
NEUROBIOLOGY OF DISEASE (2014)
SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models
Yoko Ono et al.
NEUROSCIENCE LETTERS (2014)
Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
Linda Nguyen et al.
PLOS ONE (2014)
Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
Nicholas J. Izzo et al.
PLOS ONE (2014)
ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43
Radu Stoica et al.
NATURE COMMUNICATIONS (2014)
Dynamic Interaction between Sigma-1 Receptor and Kv1.2 Shapes Neuronal and Behavioral Responses to Cocaine
Said Kourrich et al.
CELL (2013)
The σ-1 Receptor Interacts Directly with GluN1 But Not GluN2A in the GluN1/GluN2A NMDA Receptor
Dilshan Balasuriya et al.
JOURNAL OF NEUROSCIENCE (2013)
Captodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor antagonism and sigma-1 receptor agonism
Rebecca M. Ring et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the sigma-1 receptor
K. Sahlholm et al.
MOLECULAR PSYCHIATRY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Blockade of Tau Hyperphosphorylation and Aβ1-42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer's Disease
Valentine Lahmy et al.
NEUROPSYCHOPHARMACOLOGY (2013)
LACK OF SIGMA-1 RECEPTOR EXACERBATES ALS PROGRESSION IN MICE
T. A. Mavlyutov et al.
NEUROSCIENCE (2013)
Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models
Louise Hedskog et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-κB pathway
A. Hyrskyluoto et al.
CELL DEATH & DISEASE (2013)
Randomized Controlled Clinical Trial of Virtual House Calls for Parkinson Disease
E. Ray Dorsey et al.
JAMA NEUROLOGY (2013)
Stimulation of Sigma Receptors with Afobazole Blocks Activation of Microglia and Reduces Toxicity Caused by Amyloid-β25-35
Adam A. Behensky et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Afobazole Activation of σ-1 Receptors Modulates Neuronal Responses to Amyloid-β25-35
Adam A. Behensky et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Upregulated function of mitochondria-associated ER membranes in Alzheimer disease
Estela Area-Gomez et al.
EMBO JOURNAL (2012)
Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection
Rong Yang et al.
NEUROPHARMACOLOGY (2012)
Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
Renzo Mancuso et al.
NEUROTHERAPEUTICS (2012)
Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor
Michiko Fujimoto et al.
SYNAPSE (2012)
A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis
Amr Al-Saif et al.
ANNALS OF NEUROLOGY (2011)
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
Teruo Hayashi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Anti-Amnesic and Neuroprotective Actions of the Sigma-1 Receptor Agonist (-)-MR22 in Rats with Selective Cholinergic Lesion and Amyloid Infusion
Vuokko Antonini et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
Vanessa Villard et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site
Jinbin Xu et al.
NATURE COMMUNICATIONS (2011)
Demonstration of a Direct Interaction between σ-1 Receptors and Acid-Sensing Ion Channels
Stewart M. Carnally et al.
BIOPHYSICAL JOURNAL (2010)
Downregulation of NF-κB signaling by mutant huntingtin proteins induces oxidative stress and cell death
Sami Reijonen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie Crews et al.
HUMAN MOLECULAR GENETICS (2010)
Synthesis and Evaluation of a Set of 4-Phenylpiperidines and 4-Phenylpiperazines as D2 Receptor Ligands and the Discovery of the Dopaminergic Stabilizer 4[3-(Methylsulfonyl)phenyl]-1-propylpiperidine (Huntexil, Pridopidine, ACR16)
Fredrik Pettersson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Incidence of amyotrophic lateral sclerosis in Europe
Giancarlo Logroscino et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Sigma-1 Receptors Regulate Bcl-2 Expression by Reactive Oxygen Species-Dependent Transcriptional Regulation of Nuclear Factor κB
Johann Meunier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding
Felix J. Kim et al.
MOLECULAR PHARMACOLOGY (2010)
Voltage-gated sodium channel modulation by σ-receptors in cardiac myocytes and heterologous systems
Molly Johannessen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Interaction of Afobazole with σ1-Receptors
S. B. Seredenin et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25-35-Induced Toxicity in Mice
Vanessa Villard et al.
NEUROPSYCHOPHARMACOLOGY (2009)
The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Dominique Fontanilla et al.
SCIENCE (2009)
Hormesis and medicine
Edward J. Calabrese
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Neuroscience and hormesis: Overview and general findings
Edward J. Calabrese
CRITICAL REVIEWS IN TOXICOLOGY (2008)
Mechanisms of neurodegeneration in Huntington's disease
Joana M. Gil et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins
Sami Reijonen et al.
EXPERIMENTAL CELL RESEARCH (2008)
Further evidence for an antidepressant potential of the selective σ1 agonist SA4503: electrophysiological, morphological and behavioural studies
Guillaume Lucas et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions
Aoife Ni Mhaille et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Chronic treatment with a selective ligand for the sigma-1 receptor chaperone, SA4503, up-regulates BDNF protein levels in the rat hippocampus
Kazue Kikuchi-Utsumi et al.
NEUROSCIENCE LETTERS (2008)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity
Randy Singh Atwal et al.
HUMAN MOLECULAR GENETICS (2007)
Involvement of the sigma1 (σ1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41
J. Espallergues et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: Role of sigma-1 receptors
Kenji Hashimoto et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action
Linda L. Werling et al.
NEUROLOGIST (2007)
The anti-amnesic and neuroprotective effects of donepezil against amyloid β25-35 peptide-induced toxicity in mice involve an interaction with the σ1 receptor
J. Meunier et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Haloperidol induces apoptosis via the σ2 receptor system and Bcl-XS
Z. Wei et al.
PHARMACOGENOMICS JOURNAL (2006)
Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release
Y Yagasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Interaction with σ1 protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil
T Maurice et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Compensatory effect by sigma1 (σ1) receptor stimulation during alcohol withdrawal in mice performing an object recognition task
J Meunier et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Neuroprotective effects of sigma-I receptor agonists against beta-amyloid-induced toxicity
A Marrazzo et al.
NEUROREPORT (2005)
Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine
M Peeters et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over
RB Forbes et al.
AGE AND AGEING (2004)
Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases
DJ Selkoe
NATURE CELL BIOLOGY (2004)
Stages in the development of Parkinson's disease-related pathology
H Braak et al.
CELL AND TISSUE RESEARCH (2004)
σ-1 receptors (σ1 binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum:: Roles in endoplasmic reticulum lipid compartmentalization and export
T Hayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Intracellular dynamics of σ-1 receptors (σ1 binding sites) in NG108-15 cells
T Hayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Effect of the novel sigma1 receptor ligand and putative atypical antipsychotic E-5842 on BDNF mRNA expression in the rat brain
S Ovalle et al.
NEUROREPORT (2002)
Nerve growth factor-induced neurite sprouting in PC12 cells involves σ-1 receptors:: Implications for antidepressants
M Takebayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
AV Panov et al.
NATURE NEUROSCIENCE (2002)
A dose-dependent facilitation and inhibition of peripheral nerve regeneration by brain-derived neurotrophic factor
JG Boyd et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Hormesis: A generalizable and unifying hypothesis
EJ Calabrese et al.
CRITICAL REVIEWS IN TOXICOLOGY (2001)
BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain
LA Mamounas et al.
JOURNAL OF NEUROSCIENCE (2000)
分享论文
